Overall rank by patents
#31,064
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Biohaven Pharmaceutical Holding Company Ltd.
USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, active 2017–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
8
Total patents granted
2
CPC technology areas
9.8
Avg claims per patent
+200%
5-year filing velocity
The verdict
Biohaven holds 8 US patents across 2 technology areas, rank #31,064 of 50,000 tracked assignees.
- #31,064
- of 50,000 US assignees by volume
- Top 88%
- by Innovation Score (23.4/100)
- 9.8
- avg claims per patent
- +200%
- filing velocity, last 5 yrs
Portfolio overview
Biohaven Pharmaceutical Holding Company Ltd. has been granted 8 US utility patents between 2017 and 2024, placing Biohaven Pharmaceutical Holding Company Ltd. at rank #31,064 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Biohaven Pharmaceutical Holding Company Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Biohaven sits between Bioinspire Technologies, Inc. (8 patents, rank #31,060) and Bioverativ USA Inc. (8 patents, rank #31,068) - the closest US assignees by grant volume. The composite Innovation Score of 23.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 2 in the 2015–2019 window, a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Biohaven Pharmaceutical Holding Company Ltd.'s 9.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Biohaven Pharmaceutical Holding Company Ltd. against peers pursuing similar technology classes.
Who files at Biohaven's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bioinspire
BioInspire Technologies, Inc.
8 patents
- Biospex
BioSpex, Inc.
8 patents
- Biospyder
BioSpyder Technologies, Inc.
8 patents
- Biovigil Hygiene
BioVigil Hygiene Technologies, LLC
8 patents
- Biometry
Biometry Inc.
8 patents
- Bionic Power
Bionic Power Inc.
8 patents
- Bioriginal Food &…
Bioriginal Food & Science Corporation
8 patents
- Bioverativ USA
Bioverativ USA Inc.
8 patents
- Biohaven Pharmace… ◀
Biohaven Pharmaceutical Holding Company Ltd.
8 patents
What this shows Biohaven holds 8 patents at rank #31,064, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biohaven
By rank, the assignees closest to #31,064 in granted patent volume.
- Bioinspire Technologies, Inc. #31,060 · 8 patents
- Biospex, Inc. #31,061 · 8 patents
- Biospyder Technologies, Inc. #31,062 · 8 patents
- Biovigil Hygiene Technologies, Llc #31,063 · 8 patents
- Biometry Inc. #31,065 · 8 patents
- Bionic Power Inc. #31,066 · 8 patents
- Bioriginal Food & Science Corporation #31,067 · 8 patents
- Bioverativ USA Inc. #31,068 · 8 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Biohaven's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
Biohaven's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 88% higher than 12% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2020 | 2 | 25.0% |
| 2021 | 1 | 12.5% |
| 2022 | 2 | 25.0% |
| 2024 | 1 | 12.5% |
Which technologies does Biohaven Pharmaceutical Holding Company Ltd. patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Accelerating
Frequently Asked Questions
How many patents does Biohaven Pharmaceutical Holding Company Ltd. hold?
Biohaven Pharmaceutical Holding Company Ltd. holds 8 US granted patents filed between 2017 and 2024, spanning 2 technology areas.
What is Biohaven Pharmaceutical Holding Company Ltd.'s Innovation Score?
Biohaven Pharmaceutical Holding Company Ltd. has an Innovation Score of 23.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Biohaven Pharmaceutical Holding Company Ltd. focus on?
Biohaven Pharmaceutical Holding Company Ltd.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 7 patents. The company has filed patents in 2 CPC subclasses total.
Is Biohaven Pharmaceutical Holding Company Ltd.'s patent filing rate increasing or decreasing?
Biohaven Pharmaceutical Holding Company Ltd.'s recent filing velocity is +200% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Biohaven Pharmaceutical Holding Company Ltd.'s patents?
Biohaven Pharmaceutical Holding Company Ltd.'s patents average 9.8 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Biohaven Pharmaceutical Holding Company Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Biohaven's 8 grants land it in the top 88% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Biohaven ranks #31,064 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.